Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action
about
F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profiled-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptorsExploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons.Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents.Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Serotonin, inhibition, and negative mood.Emotional decision-making and its dissociable components in schizophrenia and schizoaffective disorder: a behavioural and MRI investigation.In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat.Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.Modes and nodes explain the mechanism of action of vortioxetine, a multimodal agent (MMA): actions at serotonin receptors may enhance downstream release of four pro-cognitive neurotransmitters.Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the ratEffect of dopaminergic D1 receptors on plasticity is dependent of serotoninergic 5-HT1A receptors in L5-pyramidal neurons of the prefrontal cortex.Reduced cholesterol is associated with the depressive-like behavior in rats through modulation of the brain 5-HT1A receptor.The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study.Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.Rethinking 5-HT1A receptors: emerging modes of inhibitory feedback of relevance to emotion-related behaviorSerotonin modulation of cortical neurons and networks.Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.HTR1A Polymorphisms and Clinical Efficacy of Antipsychotic Drug Treatment in Schizophrenia: A Meta-Analysis.Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical studyLong-Term Citalopram Treatment Alters the Stress Responses of the Cortical Dopamine and Noradrenaline Systems: the Role of Cortical 5-HT1A Receptors.Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophreniaCatecholamine/Serotonin interactions: systems thinking for brain function and diseaseTherapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.The preclinical profile of asenapine: clinical relevance for the treatment of schizophrenia and bipolar mania.Pharmacogenetics of clinical response to risperidone.Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia.The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis.How semantic deficits in schizotypy help understand language and thought disorders in schizophrenia: a systematic and integrative review.Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem.A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions.Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism.Development of CNS multi-receptor ligands: Modification of known D2 pharmacophoresSuccessful treatment with risperidone increases 5-HT 3A receptor gene expression in patients with paranoid schizophrenia - data from a prospective study.
P2860
Q24564963-F07B1063-8F92-42D7-9C2D-BE456D6419DCQ24564964-30E8A06A-2958-4A65-88B5-FB0D001BD6F5Q28067851-8DCA00D3-30E2-4805-BE98-A357C16ADA73Q28273285-4CC5A8AE-EE01-4FA3-965B-886857F0DCC0Q30444307-6B0DD80C-064E-403D-AB64-BBCEDAAF21A2Q30487008-163CAAEA-3904-42E6-88EB-711DA9A4227CQ30493133-C71B4D1D-6634-4852-8073-720F82BCDE76Q33318080-96B22D67-B56A-436B-960E-321B0EE49F7FQ33754259-A1225EA3-FF87-4126-B086-F32BA6ED51A6Q34238841-37006E2D-1449-4B7B-BF3B-726E52BD6570Q34350194-921FA000-A82C-4FAE-8E0B-C30ED12F69DCQ34670569-33F28C66-F795-434D-B898-0E90B1EDB931Q35179053-2A5D69DC-7E50-4875-87FD-7A8364EF2047Q35182442-7F1DEC9D-AD84-4400-8948-F415EDD18889Q35226076-A517897A-A959-4588-AA3F-375F69F17149Q35541620-3F712AB6-3F7C-46E3-8194-B4EC33F00FA4Q36382946-790B5DBA-7CD7-40AF-83C0-4EAE88D09097Q36540897-CCFB5DBF-DB30-4240-BD7C-A8A85EA3175BQ36778507-07C4F1B4-8CA1-442B-87F0-F71764AD3FBCQ36852421-5B6A145A-BDF5-442B-9519-2E671DCE34D1Q36950578-E15BF630-D6A4-407C-AF07-67CC06E3F83EQ37068729-6F3C3C06-0049-48DC-B97E-F4202ECA52F9Q37220477-CD54C6E2-0B3E-4348-9155-A25D94991015Q37224949-5324492A-E12A-4C16-936A-0B45E41C9B9EQ37231628-B962EE38-AD84-4A36-8ED7-A6A1134C2778Q37518766-9DA679C6-0BFE-4B6F-BDA4-3B9BFD80A631Q37811038-A89013B1-B2AE-46E2-9BD2-241204D81C02Q37954123-E4CBCFB4-EB14-4338-8E6F-B9077914C839Q38057380-A765E3A0-7D53-40E0-8C7A-F37020845119Q38074712-685D42D4-03A5-4C49-AA3A-D53BA217946CQ38149953-A28B2E5E-367C-49C5-8D26-12974427E667Q38178842-46077266-7570-479D-B131-6077713CD85EQ38258215-C6DED47D-6887-4CC7-97BF-CEB2BF3EEA3AQ38429406-D0AD77A1-62A2-4D54-A752-67CD8FD33730Q39271592-B8DEE08E-C223-4112-B965-0EBA51BAAD1FQ39587382-25C0A91E-7881-48DC-B1C3-ADD8D82D13FEQ40226041-878CD5C0-75C4-4BBF-A65D-E54EC5669069Q40494872-EDA0955A-C37F-4481-8081-25165E8C9F94Q40626733-840612BE-D033-4CEA-BBC7-62771021825CQ41691255-98346AD2-EC79-467D-A5FC-6945EDE60B9B
P2860
Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@ast
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@en
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@nl
type
label
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@ast
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@en
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@nl
prefLabel
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@ast
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@en
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@nl
P2093
P3181
P1476
Involvement of 5-HT1A receptor ...... atypical antipsychotic action
@en
P2093
Analía Bortolozzi
Francesc Artigas
M Cecilia Scorza
Miklos Toth
Pau Celada
P304
10831-10843
P3181
P356
10.1523/JNEUROSCI.2999-05.2005
P407
P577
2005-11-01T00:00:00Z